# MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation

> **NCT04967287** · NA · COMPLETED · sponsor: **Dopavision GmbH** · enrollment: 124 (actual)

## Conditions studied

- Myopia

## Interventions

- **DEVICE:** MyopiaX
- **DEVICE:** Myopia control spectacles

## Key facts

- **NCT ID:** NCT04967287
- **Lead sponsor:** Dopavision GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-16
- **Primary completion:** 2024-10-04
- **Final completion:** 2024-10-04
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04967287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04967287, "MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04967287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*